STX17 (Syntaxin 17) is a SNARE protein encoded by the STX17 gene located on chromosome 9q31.3. It is a member of the syntaxin family of SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) proteins that mediate membrane fusion.
STX17 is a critical component of the autophagy machinery, specifically required for autophagosome-lysosome fusion. Mutations in STX17 are associated with Parkinson's disease and dementia with Lewy bodies.[1]
The protein encoded by STX17 is STX17 Protein.[2]
STX17 is a tail-anchored SNARE protein that localizes primarily to the outer membrane of autophagosomes. Unlike other syntaxins that function at the plasma membrane or Golgi, STX17 has evolved to specialize in autophagy.
Key functions include:
- Autophagosome-lysosome fusion: Essential for autophagy completion
- ER-mitochondria contact: Maintains cellular homeostasis
- Lipid droplet dynamics: Affects lipid metabolism
| Property |
Value |
| Gene Symbol |
STX17 |
| Full Name |
Syntaxin 17 |
| Chromosome |
9q31.3 |
| NCBI Gene ID |
55276 |
| OMIM |
612598 |
| Ensembl ID |
ENSG00000143891 |
| UniProt ID |
Q9NYQ6 |
¶ Protein Structure and Function
¶ Domain Architecture
STX17 contains:
- N-terminal regulatory region: Autophagy-related functions
- SNARE domain: Membrane fusion machinery
- Transmembrane anchor: Tail-anchored membrane protein
STX17 forms a SNARE complex with:
- VAMP8: Lysosomal v-SNARE
- SNAP29: Adapter SNARE
- STX17: Autophagosomal t-SNARE
This complex mediates the final step of autophagy—the fusion of autophagosomes with lysosomes.
STX17 is essential for:
- Autophagosome maturation: Recruitment of lysosomes
- Selective autophagy: Mitophagy, xenophagy
- Cargo delivery: Complete autophagic flux
STX17 maintains:
- Mitochondria-ER contacts: MAM (mitochondria-associated membranes)
- Calcium homeostasis: Calcium transfer between organelles
- Lipid exchange: Phospholipid metabolism
Through autophagy:
- Protein aggregate clearance
- Organelle quality control
- Cellular stress response
STX17 is expressed in:
- Dopaminergic neurons: Substantia nigra pars compacta
- Cerebral cortex: Pyramidal neurons
- Hippocampus: All regions
- Cerebellum: Purkinje cells
- Motor neurons: Spinal cord
In neurons:
- Autophagosomes: Throughout soma and processes
- Lysosomes: Perinuclear and distal
- Synaptic terminals: Regulates local autophagy
- Mitochondria: MAM localization
STX17 is strongly linked to PD:
- Mutations identified: Splice site, I45V
- Inheritance: Autosomal dominant
- Mechanism: Impaired autophagy
- Pathogenesis: α-Synuclein accumulation
Related pathways:
- STX17 variants associated with DLB
- Autophagy-lysosome pathway dysfunction
- α-Synuclein Lewy body formation
- Altered autophagic flux
- Amyloid processing connections
- Tau clearance mechanisms
- Huntington's disease
- Amyotrophic lateral sclerosis
- Prion diseases
STX17 mutations cause:
- Impaired autophagosome-lysosome fusion
- Accumulation of undigested autophagosomes
- Failure to clear protein aggregates
Due to autophagy defects:
- α-Synuclein inclusions
- Damaged mitochondria
- ER stress
Dopaminergic neurons are particularly susceptible:
- High basal autophagy demand
- Complex axonal morphology
- Oxidative stress exposure
- Autophagy inducers (rapamycin, metformin)
- TFEB (transcription factor EB) activators
- Lysosomal function enhancers
- SNARE complex stabilizers
- Autophagy-specific compounds
- Lysosomal activity promoters
- AAV-STX17 delivery
- CRISPR-based approaches
- Small interfering RNA
- Autophagy induction + α-synuclein reduction
- Neuroprotective + disease-modifying
- Personalized medicine approaches
- Patient-derived iPSC neurons
- Dopaminergic cell lines
- Primary neuron cultures
- Stx17 knockout mice
- Parkinson's disease models
- Transgenic STX17 mutants
- SNARE complex purification
- Autophagic flux measurements
- Live-cell imaging
- STX17 sequencing for PD diagnosis
- Variant interpretation
- Family screening
- Autophagic flux markers
- Lysosomal function tests
- CSF biomarkers
- Autophagy modulators in trials
- Target validation needed
- Patient selection strategies
The study of Stx17 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- STX17 Mutations in Parkinson's Disease - Nature Genetics
- STX17 Protein - UniProt
- STX17 in Autophagy - Nature Cell Biology
- Syntaxin 17 in Parkinson's Disease - Brain
- Autophagy-Lysosome Pathway in Neurodegeneration - Nature Reviews Neuroscience